Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects.
Maniscalco GT, Manzo V, Ferrara AL, Perrella A, Di Battista M, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Barbato S, Servillo G, Longo K, Di Giovanni M, Scarpati B, Muggianu SM, Longo G, Russo G, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: di giulio cesare d. Mult Scler Relat Disord. 2022 Feb;58:103455. doi: 10.1016/j.msard.2021.103455. Epub 2021 Dec 18. Mult Scler Relat Disord. 2022. PMID: 34929455 Free PMC article.
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects.
Maniscalco GT, Ferrara AL, Liotti A, Manzo V, Di Battista ME, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Alfieri G, Di Iorio W, Della Rocca G, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: di giulio cesare d. Mult Scler Relat Disord. 2022 Jun;62:103800. doi: 10.1016/j.msard.2022.103800. Epub 2022 Apr 12. Mult Scler Relat Disord. 2022. PMID: 35462168 Free PMC article.
Epstein-Barr virus infection in patients with MOGAD.
Maniscalco GT, Dinoto A, Foglia MC, Di Battista ME, Moreggia O, Di Giulio Cesare D, Williams M, Rossi FW, Carta S, Chiodega V, Ferrari S, Viola A, de Paulis A, Andreone V, Mariotto S. Maniscalco GT, et al. Among authors: di giulio cesare d. Mult Scler. 2024 Dec 13:13524585241298065. doi: 10.1177/13524585241298065. Online ahead of print. Mult Scler. 2024. PMID: 39668776
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Ponzio M, Battaglia MA, Trojano M, Salivetto M, D'Ettorre A, Corrado D, Paletta P, Lepore V, Mosconi P; Comitato Scientifico del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete dei centri del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete degli assistenti di ricerca del Registro Italiano Sclerosi Multipla e Patologie Correlate. Ponzio M, et al. Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074. Epidemiol Prev. 2024. PMID: 39329242 Free article. Italian.
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system.
Scavone C, Anatriello A, Baccari I, Cantone A, Di Giulio Cesare D, Bernardi FF, Moreggia O, Liguori V, Andreone V, Maniscalco GT, Capuano A. Scavone C, et al. Among authors: di giulio cesare d. Front Neurol. 2024 Jun 27;15:1383910. doi: 10.3389/fneur.2024.1383910. eCollection 2024. Front Neurol. 2024. PMID: 38994488 Free PMC article.
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis.
Maniscalco GT, Di Giulio Cesare D, Liguori V, Manzo V, Prestipino E, Salvatore S, Di Battista ME, Moreggia O, Ziello AR, Andreone V, Scavone C, Capuano A. Maniscalco GT, et al. Among authors: di giulio cesare d. J Clin Med. 2023 Jun 23;12(13):4236. doi: 10.3390/jcm12134236. J Clin Med. 2023. PMID: 37445269 Free PMC article.
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies.
Maniscalco GT, Liotti A, Ferrara AL, Prestipino E, Salvatore S, Di Battista ME, Moreggia O, Di Giulio Cesare D, Vastano R, Belardo M, Napolitano M, Ranieri A, Longo K, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: di giulio cesare d. Mult Scler Relat Disord. 2022 Dec;68:104371. doi: 10.1016/j.msard.2022.104371. Epub 2022 Oct 23. Mult Scler Relat Disord. 2022. PMID: 36544318 Free PMC article.
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study.
Maniscalco GT, Scavone C, Mascolo A, Manzo V, Prestipino E, Guglielmi G, Aiezza ML, Cozzolino S, Bracco A, Moreggia O, Di Giulio Cesare D, Ziello AR, Falco A, Massa M, Majolo M, Raiola E, Soprano R, Russo G, Longo G, Andreone V, Capuano A. Maniscalco GT, et al. Among authors: di giulio cesare d. J Clin Med. 2022 Nov 21;11(22):6855. doi: 10.3390/jcm11226855. J Clin Med. 2022. PMID: 36431332 Free PMC article.